Go to content
Esperite N.V.

Esperite N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 26 aug 2010 - 07:17
Statutaire naam Esperite N.V.
Titel Cryo-Save Group N.V.: Revenue up 5% to €19.5 million and Net Profit up 36% to €1.3 million in first half year
Bericht Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), Europe's leading adult stem cell storage bank, has published its interim results for the six months ended 30 June 2010. Financial highlights - Revenue up 5% to €19.5 million (1HY 2009: €18.6 million) - EBITA* up 23% to €2.5 million (1HY 2009: €2.0 million) - Operating profit up 31% to €1.9 million (1HY 2009: €1.4 million) - Profit before taxation up 33% to €1.6 million (1HY 2009: €1.2 million) - Net profit up 36% to €1.3 million (1HY 2009: €0.9 million) - Basic earnings per share 13.7 euro cents (1HY 2009: 10 euro cents) - Strong net cash from operating activities €2.0 million (1HY 2009: € 2.6 million) - Solid cash position of €5.9 million as at 30 June 2010